Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

An ancillary genomics system to support the return of pharmacogenomic results.

Rasmussen LV, Smith ME, Almaraz F, Persell SD, Rasmussen-Torvik LJ, Pacheco JA, Chisholm RL, Christensen C, Herr TM, Wehbe FH, Starren JB.

J Am Med Inform Assoc. 2019 Apr 1;26(4):306-310. doi: 10.1093/jamia/ocy187.

PMID:
30778576
2.

Differences in biofilm development and antibiotic susceptibility among Streptococcus pneumoniae isolates from cystic fibrosis samples and blood cultures.

García-Castillo M, Morosini MI, Valverde A, Almaraz F, Baquero F, Cantón R, del Campo R.

J Antimicrob Chemother. 2007 Feb;59(2):301-4. Epub 2006 Dec 1.

PMID:
17142818
3.

Evaluation of 4 swab transport systems for the recovery of ATCC and clinical strains with characterized resistance mechanisms.

Morosini MI, Loza E, Gutiérrez O, Almaraz F, Baquero F, Cantón R.

Diagn Microbiol Infect Dis. 2006 Sep;56(1):19-24. Epub 2006 Jul 5.

PMID:
16822635
4.

[Comparative in vitro activity of garenoxacin (BMS-284756). Sentry program, Spain (1999-2000)].

Loza E, Cantón R, Pascual A, Tubau F, Morosini MI, Almaraz F, Perea E, Martín R, Jones RN, Baquero F.

Enferm Infecc Microbiol Clin. 2003 Oct;21(8):404-9. Spanish.

PMID:
14525705
5.

[Comparative in vitro activity of ertapenem against aerobic and anaerobic bacteria].

Loza E, Morosini MI, Cantón R, Almaraz F, Reig M, Baquero F.

Rev Esp Quimioter. 2003 Jun;16(2):209-15. Spanish.

6.

Fluoroquinolone-resistant Streptococcus pneumoniae in Spain: activities of garenoxacin against clinical isolates including strains with altered topoisomerases.

Morosini MI, Loza E, del Campo R, Almaraz F, Baquero F, Cantón R.

Antimicrob Agents Chemother. 2003 Aug;47(8):2692-5.

7.

Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.

Morosini MI, Cantón R, Loza E, del Campo R, Almaraz F, Baquero F.

J Antimicrob Chemother. 2003 Jul;52(1):50-5. Epub 2003 Jun 12.

PMID:
12805254
8.

In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.

Morosini MI, Cantón R, Loza E, Negri MC, Galán JC, Almaraz F, Baquero F.

Antimicrob Agents Chemother. 2001 Sep;45(9):2427-31.

9.

[National multicenter study of the in vitro activity of moxifloxacin against respiratory tract pathogens. Spanish Study Group on Moxifloxacin].

Loza E, Morosini M, Negri MC, Almaraz F, Cantón R, Baquero F.

Rev Esp Quimioter. 2000 Mar;13(1):37-43. Spanish.

PMID:
10855023
10.

[National Multicenter study of the in vitro activity of moxifloxacin against respiratory tract pathogens]

Loza E, Morosini M, Negri MC, Almaraz F, Cantón R, Baquero F.

Rev Esp Quimioter. 2000 Mar;13(1):37-43. Spanish.

PMID:
10878536
11.

[Vaginal hysterectomy in patients without uterine prolapse].

Nava y Sánchez R, Sandoval JB, Peñaloza JR, Martínez O, Almaraz FM, Fierro HP.

Ginecol Obstet Mex. 1975 Apr;37(222):225-36. Spanish. No abstract available.

PMID:
1140593

Supplemental Content

Loading ...
Support Center